Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Apelin on Insulin Sensitivity in Healthy Volunteers
NCT02033473Phase 1Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jan 2014
- Primary completion
- Oct 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial in insulin resistance (IR) comparing Apelin First with Placebo First (2 arms). Primary endpoint: Rate of glucose infusion. Started Jan 2014; status: completed.
02
Drugs
Apelin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02033473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033473.